| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |